-transparent.png){kind=logo}
The interaction potential of remoxipride was investigated with biperiden, warfarin, diazepam, and ethanol. The studies were conducted in 12 healthy volunteers each of whom received single doses of remoxipride, the interacting drug, and the combination in a randomized crossover design. Remoxipride and biperidene had no influence on each other's pharmacokinetics. The pharmacokinetics of warfarin enantiomers were uninfluenced by remoxipride. Ethanol and diazepam had no effect on the pharmacokinetics of remoxipride. The effect of remoxipride on the elevation of plasma prolactin levels was not modified by biperiden and the effect of warfarin on the prolongation of prothrombin time was uninfluened by remoxipride. Remoxipride showed no pharmacokinetic interaction with any of the drugs studied, nor was any pharmacodynamic interaction observed in the remoxipride versus biperiden and remoxipride versus warfarin studies.
W Yisak, and
C von Bahr, and
L Farde, and
M Grind, and
M Mattila, and
S Ogenstad
October 2015,
Clinical pharmacokinetics,
W Yisak, and
C von Bahr, and
L Farde, and
M Grind, and
M Mattila, and
S Ogenstad
January 1982,
European journal of rheumatology and inflammation,
W Yisak, and
C von Bahr, and
L Farde, and
M Grind, and
M Mattila, and
S Ogenstad
September 1997,
Journal of human hypertension,
W Yisak, and
C von Bahr, and
L Farde, and
M Grind, and
M Mattila, and
S Ogenstad
September 1991,
Clinical pharmacokinetics,
W Yisak, and
C von Bahr, and
L Farde, and
M Grind, and
M Mattila, and
S Ogenstad
September 1970,
Anesthesiology,
W Yisak, and
C von Bahr, and
L Farde, and
M Grind, and
M Mattila, and
S Ogenstad
January 2014,
Drug metabolism and drug interactions,
W Yisak, and
C von Bahr, and
L Farde, and
M Grind, and
M Mattila, and
S Ogenstad
May 2019,
Clinical pharmacology and therapeutics,
W Yisak, and
C von Bahr, and
L Farde, and
M Grind, and
M Mattila, and
S Ogenstad
August 1989,
Wiener medizinische Wochenschrift (1946),
W Yisak, and
C von Bahr, and
L Farde, and
M Grind, and
M Mattila, and
S Ogenstad
March 1967,
Molecular pharmacology,
W Yisak, and
C von Bahr, and
L Farde, and
M Grind, and
M Mattila, and
S Ogenstad
January 1992,
Clinical neuropharmacology,
